The endometrial effects of SERMs

被引:29
作者
Cano, A [1 ]
Hermenegildo, C [1 ]
机构
[1] Fac Med, Dept Pediat Obstet & Gynecol, Valencia 46010, Spain
关键词
cancer; endometrium; raloxifene; SERMs; tamoxifen;
D O I
10.1093/humupd/6.3.244
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The ideal selective oestrogen receptor modulator (SERM) mould retain an oestrogen-like effect on the bones, the heart and cardiovascular apparatus, and the central nervous system, while acting as an anti-oestrogen on the breast and the genital tract. It seems, however, that such a compound is not available for clinical use get. The uterine tissue, and particularly the endometrium, defines an area of special interest in the SERM action, since endometrial hyperplasia and cancer has been linked to agonistic oestrogen effects. Additionally, tamoxifen, the SERM which accumulates most of the clinical experience, has been associated with stimulatory effects on endometrium, including the development of cancer. In contrast, the more recent benzothiophenes, led by raloxifene, seem to operate as endometrial antagonists, thus providing an interesting alternative for clinical use. This review analyses the endometrial action of tamoxifen, including the information gathered from laboratory models, the observed endometrial effects in women using tamoxifen, and the epidemiological and molecular data which link the use of tamoxifen with endometrial cancer. A parallel examination of the raloxifene data presents the available experimental and clinical information, suggesting the endometrial neutrality of this compound.
引用
收藏
页码:244 / 254
页数:11
相关论文
共 115 条
[1]   CHANGES MIMICKING ENDOMETRIAL NEOPLASIA IN POSTMENOPAUSAL, TAMOXIFEN-TREATED WOMEN WITH BREAST-CANCER - A TRANSVAGINAL DOPPLER STUDY [J].
ACHIRON, R ;
LIPITZ, S ;
SIVAN, E ;
GOLDENBERG, M ;
HOROVITZ, A ;
FRENKEL, Y ;
MASHIACH, S .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1995, 6 (02) :116-120
[2]   TOO MANY RODENT CARCINOGENS - MITOGENESIS INCREASES MUTAGENESIS [J].
AMES, BN ;
GOLD, LS .
SCIENCE, 1990, 249 (4972) :970-971
[3]   Activity of raloxifene in immature and ovariectomized rat uterotrophic assays [J].
Ashby, J ;
Odum, J ;
Foster, JR .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 25 (03) :226-231
[4]   Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles [J].
Baker, VL ;
Draper, M ;
Paul, S ;
Allerheiligen, S ;
Glant, M ;
Shifren, J ;
Jaffe, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :6-13
[5]   DIFFERENTIALLY REGULATED IMMEDIATE-EARLY GENES IN THE RAT UTERUS [J].
BIGSBY, RM ;
LI, AX .
ENDOCRINOLOGY, 1994, 134 (04) :1820-1826
[6]   RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS [J].
BLACK, LJ ;
SATO, M ;
ROWLEY, ER ;
MAGEE, DE ;
BEKELE, A ;
WILLIAMS, DC ;
CULLINAN, GJ ;
BENDELE, R ;
KAUFFMAN, RF ;
BENSCH, WR ;
FROLIK, CA ;
TERMINE, JD ;
BRYANT, HU .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :63-69
[7]   ANTAGONISM OF ESTROGEN ACTION WITH A NEW BENZOTHIOPHENE DERIVED ANTI-ESTROGEN [J].
BLACK, LJ ;
JONES, CD ;
FALCONE, JF .
LIFE SCIENCES, 1983, 32 (09) :1031-1036
[8]   UTERINE BIOASSAY OF TAMOXIFEN, TRIOXIFENE AND A NEW ESTROGEN ANTAGONIST (LY117018) IN RATS AND MICE [J].
BLACK, LJ ;
GOODE, RL .
LIFE SCIENCES, 1980, 26 (17) :1453-1458
[9]   EVIDENCE FOR BIOLOGICAL ACTION OF THE ANTI-ESTROGENS LY117018 AND TAMOXIFEN BY DIFFERENT MECHANISMS [J].
BLACK, LJ ;
GOODE, RL .
ENDOCRINOLOGY, 1981, 109 (03) :987-989
[10]   Effects of raloxifene hydrochloride on the endometrium of postmenopausal women [J].
Boss, SM ;
Huster, WJ ;
Neild, JA ;
Glant, MD ;
Eisenhut, CC ;
Draper, MW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (06) :1458-1464